Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay
Open Access
- 7 April 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Abstract
Prostate cancer remains the most common non-cutaneous malignancy among men in the United States. To discover potential serum-based biomarkers for high-risk prostate cancer, we performed a high-multiplex immunoassay utilizing patient-matched pre-operative and post-operative serum samples from ten men with high-grade and high-volume prostate cancer. Our study identified six (CASP8, MSLN, FGFBP1, ICOSLG, TIE2 and S100A4) out of 174 proteins that were significantly decreased after radical prostatectomy. High levels of CASP8 were detected in pre-operative serum samples when compared to post-operative serum samples and serum samples from patients with benign prostate hyperplasia (BPH). By immunohistochemistry, CASP8 protein was expressed at higher levels in prostate cancer tissues compared to non-cancerous and BPH tissues. Likewise, CASP8 mRNA expression was significantly upregulated in prostate cancer when compared to benign prostate tissues in four independent clinical datasets. In addition, mRNA levels of CASP8 were higher in patients with recurrent prostate cancer when compared to patients with non-recurrent prostate cancer and high expression of CASP8 was associated with worse disease-free survival and overall survival in renal cancer. Together, our results suggest that CASP8 may potentially serve as a biomarker for high-risk prostate cancer and possibly renal cancer.Keywords
Funding Information
- National Institutes of Health (R37CA240822)
This publication has 55 references indexed in Scilit:
- Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder CancerClinical Cancer Research, 2012
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinomaThe Prostate, 2009
- High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomasBMC Cancer, 2009
- A Breast Cancer Risk Haplotype in the Caspase-8 GeneCancer Research, 2009
- Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome ProfilingClinical Cancer Research, 2009
- Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic processBMC Cancer, 2007
- A common coding variant in CASP8 is associated with breast cancer riskNature Genetics, 2007
- The Angiogenic Switch Molecule, Secreted FGF-Binding Protein, an Indicator of Early Stages of Pancreatic and Colorectal AdenocarcinomaSeminars in Oncology, 2006
- Gene expression analysis of prostate cancersMolecular Carcinogenesis, 2002